
### [NCIT:C3105](http://purl.obolibrary.org/obo/NCIT_C3105)
**Label:** Von Hippel-Lindau Syndrome

**Subclasses:** 

**Class expressions from DL-Learner:**

- [NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma) 55.56%
- [NCIT:C18261](http://purl.obolibrary.org/obo/NCIT_C18261) (VHL Gene) 55.56%
- [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) and [NCIT:C6974](http://purl.obolibrary.org/obo/NCIT_C6974) (Neoplasm of Uncertain Histogenesis) 55.56%
- [NCIT:C3801](http://purl.obolibrary.org/obo/NCIT_C3801) (Hemangioblastoma) and [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) 55.56%
- Thing 52.40%
- [NCIT:C3263](http://purl.obolibrary.org/obo/NCIT_C3263) (Neoplasm by Site) 42.87%
- [NCIT:C3262](http://purl.obolibrary.org/obo/NCIT_C3262) (Neoplasm) 42.49%
- [NCIT:C27551](http://purl.obolibrary.org/obo/NCIT_C27551) (Disorder by Site) 41.14%
- [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) 40.91%
- [NCIT:C3030](http://purl.obolibrary.org/obo/NCIT_C3030) (Eye Neoplasm) 40.91%
- [NCIT:C4741](http://purl.obolibrary.org/obo/NCIT_C4741) (Neoplasm by Morphology) and [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) 40.91%
- [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) and (not ([NCIT:C40190](http://purl.obolibrary.org/obo/NCIT_C40190) (Cervical Verrucous Carcinoma))) 40.91%
- [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) and (not ([NCIT:C4019](http://purl.obolibrary.org/obo/NCIT_C4019) (Paget Disease and Intraductal Carcinoma of the Breast))) 40.91%
- [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) and (not ([NCIT:C40189](http://purl.obolibrary.org/obo/NCIT_C40189) (Cervical Basaloid Carcinoma))) 40.91%
- [NCIT:C4800](http://purl.obolibrary.org/obo/NCIT_C4800) (Retinal Neoplasm) and (not ([NCIT:C40187](http://purl.obolibrary.org/obo/NCIT_C40187) (Cervical Keratinizing Squamous Cell Carcinoma))) 40.91%


